Autonomous Defense Technology Private

Shield AI

The combat-proven AI pilot company at the center of the autonomous defense buildout.

Last Valuation $12.7B
2026 Revenue (est.) $540M+
Growth Rate 80%+
Founded 2015
Shield AI builds the pilot. Anduril builds the brain. Both are essential to the autonomous combat aircraft program, and Shield's valuation has reflected that bifurcation, growing from $5.3B to $12.7B in one year.

Business Overview

Shield AI is a defense technology company founded in 2015 by Brandon and Ryan Tseng (a former Navy SEAL) and Andrew Reiter. The flagship product is Hivemind, an AI pilot platform designed for operation in DDIL (disconnected, degraded, intermittent, or low-bandwidth) environments — meaning aircraft can fly autonomously without GPS or external communication. Hivemind has been combat-deployed since 2018 and integrated across F-16 fighter jets, MQ-20 drones, V-BAT surveillance drones, and the U.S. Air Force's Collaborative Combat Aircraft program.

Financial Profile

In March 2026, Shield AI raised $1.5 billion in a Series G co-led by Advent International and JPMorgan Chase's Security and Resiliency Initiative, plus $500 million in preferred equity from Blackstone — a combined $2 billion raise at a $12.7 billion post-money valuation. The company projects more than 80% revenue growth in 2026, equating to at least $540 million in revenue. The valuation represents a 140% increase from the $5.3 billion mark set in March 2025.

Strategic Positioning

Shield AI was selected for the U.S. Air Force's Collaborative Combat Aircraft prototype program in February 2026. The pending acquisition of Aechelon Technology (a tactical simulation software firm) will accelerate the Hivemind Foundation Model for Defense. The company is also developing X-BAT, a VTOL stealth fighter drone, with first flight expected by end of 2026 and full operational validation targeted for 2028.

Bull Case

Defense spending is structurally rising globally, with the Pentagon's Replicator program a direct tailwind. Combat-proven Hivemind has the only operational autonomous pilot platform. CCA program selection validates Shield's position alongside Anduril in the next-generation defense stack.

Bear Case

Anduril ($60B valuation, $2.1B revenue) is significantly larger and operates in adjacent markets. Defense procurement cycles are unpredictable and politically sensitive. X-BAT delivery timeline of 2028 leaves a multi-year period before key revenue catalysts.

Key Risks